Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

The nondichotomy between lethal catatonia and neuroleptic malignant syndrome.

Carroll BT, Taylor RE.

J Clin Psychopharmacol. 1997 Jun;17(3):235-8. No abstract available.

PMID:
9169979
2.

The neuroleptic malignant syndrome and its differentiation from lethal catatonia.

Fleischhacker WW, Unterweger B, Kane JM, Hinterhuber H.

Acta Psychiatr Scand. 1990 Jan;81(1):3-5. Review.

PMID:
2184638
3.

[Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].

Asztalos Z, Egervári L, Andrássy G, Faludi G, Frecska E.

Neuropsychopharmacol Hung. 2014 Mar;16(1):19-28. Review. Hungarian.

4.

[Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].

Heils A, Lesch KP.

Fortschr Neurol Psychiatr. 1997 Jan;65(1):8-15. Review. German.

PMID:
9132369
5.

Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome.

Castillo E, Rubin RT, Holsboer-Trachsler E.

Am J Psychiatry. 1989 Mar;146(3):324-8. Review.

PMID:
2645794
6.

Neuroleptic malignant syndrome and catatonia: one entity or two?

Fink M.

Biol Psychiatry. 1996 Jan 1;39(1):1-4. Review. No abstract available.

PMID:
8719118
7.

[Catatonic syndrome and neuroleptic malignant syndrome].

Ruzikowska A.

Psychiatr Pol. 1999 May-Jun;33(3):415-25. Review. Polish.

PMID:
10786241
8.

The evaluation and management of patients with neuroleptic malignant syndrome.

Bhanushali MJ, Tuite PJ.

Neurol Clin. 2004 May;22(2):389-411. Review.

PMID:
15062519
9.

Catatonia. 2: Diagnosis, management and prognosis.

Clark T, Rickards H.

Hosp Med. 1999 Nov;60(11):812-4. Review.

PMID:
10707192
10.

The many varieties of catatonia.

Fink M, Taylor MA.

Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 1:I8-13. Review.

PMID:
11776271
11.

Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology.

Northoff G.

J Neural Transm (Vienna). 2002 Dec;109(12):1453-67. Review.

PMID:
12486486
12.

[Neuroleptic malignant syndrome--rare diagnosis with high mortality].

Petersén A, Lundberg L.

Lakartidningen. 2009 Apr 28-May 12;106(18-19):1273-6. Review. Swedish. No abstract available.

PMID:
19537499
13.

[Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature].

Mann SC, Auriacombe M, Macfadden W, Caroff SN, Cabrina Campbell E, Tignol J.

Encephale. 2001 May-Jun;27(3):213-6. Review. French.

PMID:
11488250
14.

Drug-induced catatonia.

Duggal HS, Singh I.

Drugs Today (Barc). 2005 Sep;41(9):599-607. Review.

PMID:
16341291
15.

Movement disorder emergencies.

Kipps CM, Fung VS, Grattan-Smith P, de Moore GM, Morris JG.

Mov Disord. 2005 Mar;20(3):322-34. Review.

PMID:
15584031
16.

Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma.

Lang FU, Lang S, Becker T, Jäger M.

Psychopharmacology (Berl). 2015 Jan;232(1):1-5. doi: 10.1007/s00213-014-3807-8. Epub 2014 Nov 20. Review.

PMID:
25407348
17.

Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?

Gurrera RJ.

Clin Neuropharmacol. 2002 Jul-Aug;25(4):183-93. Review.

PMID:
12151905
18.

[Is lethal catatonia a non-drug induced malignant syndrome?].

Miyoshi K.

Seishin Shinkeigaku Zasshi. 2005;107(11):1141-6. Review. No abstract available.

PMID:
16477731
19.

[Malignant neuroleptic syndrome].

Martínez E, Domingo P, Lloret J.

Med Clin (Barc). 1994 Feb 12;102(5):181-8. Review. Spanish. No abstract available.

PMID:
8127169
20.

Neuroleptic malignant syndrome: a review.

Sewell DD, Jeste DV.

Yakubutsu Seishin Kodo. 1989 Sep;9(3):319-33. Review. No abstract available.

PMID:
2690542

Supplemental Content

Support Center